Skip to main content
. 2021 Mar 17;11(3):e044010. doi: 10.1136/bmjopen-2020-044010

Figure 2.

Figure 2

Comparisons of cohort characteristics. Rate ratios comparing baseline characteristics of people taking ACEis with people taking ARBs. ACEi, ACE inhibitor; ARB, angiotensin receptor blocker; DM, diabetes mellitus; HTN, hypertension; MA, Medicare Advantage.